Skip to main content
Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
8.16
+0.45 (5.84%)
At close: Mar 9, 2026, 4:00 PM EDT
8.28
+0.12 (1.47%)
After-hours: Mar 9, 2026, 6:28 PM EDT

Gyre Therapeutics Revenue

Gyre Therapeutics had revenue of $30.56M in the quarter ending September 30, 2025, with 19.92% growth. This brings the company's revenue in the last twelve months to $107.27M, up 2.13% year-over-year. In the year 2024, Gyre Therapeutics had annual revenue of $105.76M, down -6.78%.

Revenue (ttm)
$107.27M
Revenue Growth
+2.13%
P/S Ratio
6.91
Revenue / Employee
$185,259
Employees
579
Market Cap
741.67M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024105.76M-7.69M-6.78%
Dec 31, 2023113.45M11.16M10.91%
Dec 31, 2022102.29M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

GYRE News

More News